Hoskin P - Search Results

1

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort^†: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A… See abstract for full author list ➔ Witjes JA, et al. Among authors: hoskin p. Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19. Eur Urol. 2020. PMID: 31753752 Free article.

2

Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.

Rades D, Stalpers LJ, Veninga T, Rudat V, Schulte R, Hoskin PJ. Rades D, et al. J Urol. 2006 Feb;175(2):552-6. doi: 10.1016/S0022-5347(05)00241-7. J Urol. 2006. PMID: 16406994

3

Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy.

Salembier C, Lavagnini P, Nickers P, Mangili P, Rijnders A, Polo A, Venselaar J, Hoskin P; GEC ESTRO PROBATE Group. Salembier C, et al. Among authors: hoskin p. Radiother Oncol. 2007 Apr;83(1):3-10. doi: 10.1016/j.radonc.2007.01.014. Epub 2007 Feb 26. Radiother Oncol. 2007. PMID: 17321620

4

Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy.

Polo A, Salembier C, Venselaar J, Hoskin P; PROBATE group of the GEC ESTRO. Polo A, et al. Among authors: hoskin p. Radiother Oncol. 2010 Jan;94(1):12-23. doi: 10.1016/j.radonc.2009.12.012. Epub 2010 Jan 13. Radiother Oncol. 2010. PMID: 20074822 Review.

5

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M. Dickinson L, et al. Among authors: hoskin pj. Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21. Eur Urol. 2011. PMID: 21195536

6

A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.

Parker CC, Pascoe S, Chodacki A, O'Sullivan JM, Germá JR, O'Bryan-Tear CG, Haider T, Hoskin P. Parker CC, et al. Among authors: hoskin p. Eur Urol. 2013 Feb;63(2):189-97. doi: 10.1016/j.eururo.2012.09.008. Epub 2012 Sep 13. Eur Urol. 2013. PMID: 23000088 Clinical Trial.

7

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.

Hoskin PJ, Colombo A, Henry A, Niehoff P, Paulsen Hellebust T, Siebert FA, Kovacs G. Hoskin PJ, et al. Radiother Oncol. 2013 Jun;107(3):325-32. doi: 10.1016/j.radonc.2013.05.002. Epub 2013 Jun 14. Radiother Oncol. 2013. PMID: 23773409 Free article. Review.

8

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.

Eustace A, Irlam JJ, Taylor J, Denley H, Agrawal S, Choudhury A, Ryder D, Ord JJ, Harris AL, Rojas AM, Hoskin PJ, West CM. Eustace A, et al. Radiother Oncol. 2013 Jul;108(1):40-7. doi: 10.1016/j.radonc.2013.05.017. Epub 2013 Jun 14. Radiother Oncol. 2013. PMID: 23773411 Free PMC article. Clinical Trial.

9

Second primary cancers after radiation for prostate cancer: a review of data from planning studies.

Murray L, Henry A, Hoskin P, Siebert FA, Venselaar J; BRAPHYQS/PROBATE group of the GEC ESTRO. Murray L, et al. Among authors: hoskin p. Radiat Oncol. 2013 Jul 8;8:172. doi: 10.1186/1748-717X-8-172. Radiat Oncol. 2013. PMID: 23835163 Free PMC article. Review.

10

Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection.

Salembier C, Rijnders A, Henry A, Niehoff P, André Siebert F, Hoskin P. Salembier C, et al. Among authors: hoskin p. J Contemp Brachytherapy. 2013 Jun;5(2):63-9. doi: 10.5114/jcb.2013.36174. Epub 2013 Jun 28. J Contemp Brachytherapy. 2013. PMID: 23878549 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters